Alteration of renal carnitine metabolism by anticonvulsant treatment.
We administered therapeutic doses of valproic acid (VPA), carbamazepine (CBZ), phenytoin (PHT), and phenobarbital (PHB) to mice for 7 days, and 8 hours after the final dose we measured the concentrations of carnitine in serum, liver, kidney, skeletal muscle, and heart, and in the 7 days' accumulated urine. The results for serum and urine show that VPA induced a significant increase in renal clearance of acylcarnitine without affecting that of free carnitine, whereas CBZ, PHT, and PHB significant increased clearance of free carnitine but not that of acylcarnitine. Thus, VPA appears to reduce tubular resorption of acylcarnitine, and CBZ, PHT, and PHB appear to reduce tubular resorption of free carnitine.
Camiña
M F
MF
Department of Biochemistry (Faculty of Pharmacy), Universidad de Santiago de Compostela, Spain.
Rozas
I
I
Castro-Gago
M
M
Paz
J M
JM
Alonso
C
C
Rodriguez-Segade
S
S
D000641:Ammonia / Q000097:blood; D000818:Animals; D000927:Anticonvulsants / Q000097:blood / Q000494:pharmacology*; D002220:Carbamazepine / Q000494:pharmacology; D002331:Carnitine / Q000097:blood / Q000378:metabolism* / Q000652:urine; D008297:Male; D051379:Mice; D010634:Phenobarbital / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D014635:Valproic Acid / Q000494:pharmacology
D000927:Anticonvulsants; D002220:Carbamazepine; D014635:Valproic Acid; D010672:Phenytoin; D000641:Ammonia; D002331:Carnitine; D010634:Phenobarbital